Sejong Medical KRX:258830KOSDAQ

세종메디칼 · Korean news coverage and regulatory filings, organized.

Articles, 24h2
Articles, 7 days13
DART filings, 7 days0
Articles tracked13since Sep 11

In Q2 2026, Sejong Medical reported revenue of ₩5.0bn, up 7.1% year on year, and operating profit of ₩1.4bn. Sejong Medical (세종메디칼) appeared in 13 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 11 with 9 articles.

Sejong Medical quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩5.0bn+7.1%₩1.4bn₩1.9bn
Q1 2026₩4.9bn+9.5%₩927m₩978m
Q4 2025 derived₩4.5bn+0.9%₩673m−₩3.2bn
Q3 2025₩4.9bn-0.6%₩1.1bn₩1.2bn
Q2 2025₩4.6bn+4.2%₩740m−₩140m
Q1 2025₩4.4bn-12.2%−₩293m₩2.1bn
Q4 2024 derived₩4.5bn-7.3%₩250m−₩358m
Q3 2024₩5.0bn+5.9%₩249m−₩365m

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Sejong Medical top stories 2 weeks, by number of outlets

  1. 1
    [포토] 제넨셀·세종메디칼 피해자 기자회견
    3 outlets · 3 articlesFirst report Sep 11 11:25 아시아경제
  2. 2
    주가 8760원에서 412원으로…세종메디칼 상폐 위기까지 무슨 일이
    1 outlets · 1 articlesFirst report Sep 15 11:05 비즈한국
  3. 3
  4. 4
  5. 5
    '세종메디칼 피해' 주주들 "김승원·제넨셀 의혹 밝혀야"
    1 outlets · 1 articlesFirst report Sep 11 12:42 아이뉴스24
  6. 6
    세종메디칼 주주들 "재수사나 특검 통해 진실 밝혀져야"
    1 outlets · 1 articlesFirst report Sep 11 12:55 한국경제

Latest Sejong Medical news Korean headlines